Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Scientist, Analytical Development

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Jul 18, 2021

View more

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We want all of our people to go beyond what is possible. We aren't constrained by typical end rails, and we aren't out to just treat people. We're all in this for something more. We're driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How You Will Achieve More At Intellia:

Intellia is seeking a motivated Analytical Development candidate for a position as Bioassay Scientist to work on our gene and cell therapy clinical programs. The candidate must have a strong background and hands-on experience in molecular and binding/immunoassays. The successful candidate will take a leading role in defining, developing and optimizing new methods, as well as facilitating method transfers, qualifications and validations. He/She will be responsible for analytical development, qualification, and operational support for preclinical through late stage clinical development programs for Intellia Therapeutics.

  • Develop, optimize, and qualify molecular-based, immunoassay, and characterization assays with established assay acceptance criteria for gene & cell therapy product characterization, lot release and stability testing
  • Technology Transfer: Act as SME in tech transfer of analytical methods, protocols/procedures, and know-how from internal labs to external labs
  • Lab operation: Routine and non-routine analytical testing, coordination with internal/external PD or cGMP manufacturing on sample testing, maintain laboratory equipment, maintain laboratory sample inventory for potency assay, compile and present data to support process development and developmental stability studies
  • Evaluate novel assay technologies and methodologies that could improve existing analytical methods
  • Knowledge of GxP regulations
  • Author and review SOPs, development reports, and assist in the preparation of CMC regulatory submissions
  • Assist in maintaining/qualification of critical reagent supply for assigned methods
  • Work collaboratively with Analytical Development, Process Development and Quality teams to gather and analyze data to achieve method readiness
  • Work closely with, and support quality control on investigations, OOS, OOTs and release assay trouble shooting
  • Maintain well documented records of analytical data, laboratory notebooks, execution of assays and stability data

About You :
  • PhD degree in Biochemistry, Cell & Molecular biology, Genetics, or related disciplines with minimum 2+ years of experience; Master's degree with minimum 5+ years of experience; BS with minimum 10+ years of experience in biotech or pharma industry with primary focus on biologics and/or gene and cell therapy
  • Excellent communication, technical and organizational skills are required
  • Managerial experience desirable
  • Critical thinking, troubleshooting and attention to detail is a must. Candidate will be required to plan & execute experiments as well as analyze data generated at other sites for method improvements
  • AAV and/or Cell Therapy experience is highly desired
  • In depth knowledge of molecular assays such as qPCR, ddPCR and/or ELISA and enzymatic assays experience is required
  • Prior experience or technical knowledge in NGS is desirable
  • Knowledge of FDA, cGMP, and ICH regulatory requirements in the context of bioassay/potency assay development and qualification is desired
  • Experience and knowledge of QC and GMP regulations is essential
  • Extensive experience in cell culture, cell line development is required
  • Must be able generate SOPs and technical reports with appropriate level of detail, as well as perform bioassay assay trending
  • Must have experience working with CROs
  • Good understanding of statistical methods/tools for data analysis is strong plus
  • Team player, good interpersonal and organizational skills

#LI-KO1

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert